These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 35117304)

  • 1. Is there an efficacy-effectiveness gap between randomized controlled trials and real-world studies in colorectal cancer: a systematic review and meta-analysis.
    Zhang X; Fu S; Meng R; Ren Y; Shang Y; Tian L
    Transl Cancer Res; 2020 Nov; 9(11):6963-6987. PubMed ID: 35117304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness of ocriplasmin in real-world settings: A systematic literature review, meta-analysis, and comparison with randomized trials.
    Khanani AM; Constantine RN; Blot KH; Lescrauwaet B; Szurman P
    Acta Ophthalmol; 2021 Sep; 99(6):e823-e836. PubMed ID: 33369248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral versus intravenous fluoropyrimidines for colorectal cancer.
    Chionh F; Lau D; Yeung Y; Price T; Tebbutt N
    Cochrane Database Syst Rev; 2017 Jul; 7(7):CD008398. PubMed ID: 28752564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A meta-analysis of effectiveness of real-world studies of antipsychotics in schizophrenia: Are the results consistent with the findings of randomized controlled trials?
    Katona L; Bitter I; Czobor P
    Transl Psychiatry; 2021 Oct; 11(1):510. PubMed ID: 34615850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcatheter aortic valve implantation versus surgical aortic valve replacement for treatment of severe aortic stenosis: comparison of results from randomized controlled trials and real-world data.
    Wang D; Huang L; Zhang Y; Cheng Z; Zhang X; Ren P; Hong Q; Kang D
    Braz J Cardiovasc Surg; 2020 Jun; 35(3):346-367. PubMed ID: 32549107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The efficacy and toxicity of maintenance therapy with bevacizumab plus pemetrexed versus bevacizumab/pemetrexed alone for stage IIIB/IV nonsquamous non-small cell lung cancer: A meta-analysis of randomized controlled trials.
    Liu M; Luo N; Fang Z; Liu Q; Yi F; Wei Y; Zhang X; Zhang W
    J Clin Pharm Ther; 2022 Feb; 47(2):157-167. PubMed ID: 34617297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Role of Maintenance Strategies in Metastatic Colorectal Cancer: A Systematic Review and Network Meta-analysis of Randomized Clinical Trials.
    Sonbol MB; Mountjoy LJ; Firwana B; Liu AJ; Almader-Douglas D; Mody K; Hubbard J; Borad M; Ahn DH; Murad MH; Bekaii-Saab T
    JAMA Oncol; 2020 Mar; 6(3):e194489. PubMed ID: 31855256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systematic review and economic evaluation of bevacizumab and cetuximab for the treatment of metastatic colorectal cancer.
    Tappenden P; Jones R; Paisley S; Carroll C
    Health Technol Assess; 2007 Mar; 11(12):1-128, iii-iv. PubMed ID: 17346499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective Vascular Endothelial Growth Factor Receptor Inhibitors Provide Limited Benefits for Metastatic Colorectal Cancer: A Meta-Analysis.
    Fan Q; Lv W; Xu Y; Dong Y; Xiang Z; Wang J
    Curr Pharm Des; 2020; 26(26):3171-3186. PubMed ID: 32067605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rheumatoid arthritis patients treated in trial and real world settings: comparison of randomized trials with registries.
    Kilcher G; Hummel N; Didden EM; Egger M; Reichenbach S;
    Rheumatology (Oxford); 2018 Feb; 57(2):354-369. PubMed ID: 29149289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. First-line cetuximab versus bevacizumab for RAS and BRAF wild-type metastatic colorectal cancer: a systematic review and meta-analysis.
    Zheng B; Wang X; Wei M; Wang Q; Li J; Bi L; Deng X; Wang Z
    BMC Cancer; 2019 Mar; 19(1):280. PubMed ID: 30922269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Systematic Review and Network Meta-Analysis of Biologic Agents in the First Line Setting for Advanced Colorectal Cancer.
    Kumachev A; Yan M; Berry S; Ko YJ; Martinez MC; Shah K; Chan KK
    PLoS One; 2015; 10(10):e0140187. PubMed ID: 26474403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemotherapeutic Effectiveness of Combining Cetuximab for Metastatic Colorectal Cancer Treatment: A System Review and Meta-Analysis.
    Li R; Liang M; Liang X; Yang L; Su M; Lai KP
    Front Oncol; 2020; 10():868. PubMed ID: 32547954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bisphosphonates in multiple myeloma: a network meta-analysis.
    Mhaskar R; Redzepovic J; Wheatley K; Clark OA; Miladinovic B; Glasmacher A; Kumar A; Djulbegovic B
    Cochrane Database Syst Rev; 2012 May; (5):CD003188. PubMed ID: 22592688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of cetuximab-related skin toxicity in metastatic colorectal cancer patients and its correlation with parameters of the epidermal growth factor receptor signal transduction pathway: results from a randomized trial of the GERMAN AIO CRC Study Group.
    Stintzing S; Kapaun C; Laubender RP; Jung A; Neumann J; Modest DP; Giessen C; Moosmann N; Wollenberg A; Kirchner T; Heinemann V
    Int J Cancer; 2013 Jan; 132(1):236-45. PubMed ID: 22644776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and toxicity of adding cetuximab to chemotherapy in the treatment of metastatic colorectal cancer: a meta-analysis from 12 randomized controlled trials.
    Lv ZC; Ning JY; Chen HB
    Tumour Biol; 2014 Dec; 35(12):11741-50. PubMed ID: 25417200
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Totality of evidence of the effectiveness of repurposed therapies for COVID-19: Can we use real-world studies alongside randomized controlled trials?
    Mandema J; Montgomery H; Dron L; Fu S; Russek-Cohen E; Bromley C; Mouksassi S; Lalonde A; Springford A; Tsai L; Ambery P; McNair D; Qizilbash N; Pocock S; Zariffa N
    Clin Transl Sci; 2023 Oct; 16(10):1842-1855. PubMed ID: 37466279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation of Progression-Free Survival Rate at 6 Months and Objective Response for Estimating Overall Survival in Immune Checkpoint Inhibitor Trials: A Systematic Review and Meta-analysis.
    Kok PS; Cho D; Yoon WH; Ritchie G; Marschner I; Lord S; Friedlander M; Simes J; Lee CK
    JAMA Netw Open; 2020 Sep; 3(9):e2011809. PubMed ID: 32897371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of omalizumab in children and adolescents with moderate-to-severe asthma: A systematic literature review.
    Corren J; Kavati A; Ortiz B; Colby JA; Ruiz K; Maiese BA; Cadarette SM; Panettieri RA
    Allergy Asthma Proc; 2017 Jul; 38(4):250-263. PubMed ID: 28631599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cetuximab for esophageal cancer: an updated meta-analysis of randomized controlled trials.
    Huang ZH; Ma XW; Zhang J; Li X; Lai NL; Zhang SX
    BMC Cancer; 2018 Nov; 18(1):1170. PubMed ID: 30477458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.